Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B N La Du

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Clinical Pharmacology and Therapeutics|November 1, 1977
Effects of GRAS substances on pharmacologic effects of drugsB N La Du
Acta Anaesthesiologica Scandinavica|February 1, 1995
Butyrylcholinesterase variants and the new methods of molecular biologyB N La Du
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1983
Commentary: drug metabolism and pharmacogeneticsB N La Du
Trends in Pharmacological Sciences|August 1, 1989
Identification of human serum cholinesterase variants using the polymerase chain reaction amplification techniqueB N La Du
American Journal of Human Genetics|June 13, 1998
Are we ready to try to cure alkaptonuria?B N La Du
Nature Medicine|November 1, 1996
Structural and functional diversity of paraoxonasesB N La Du
Arteriosclerosis, Thrombosis, and Vascular Biology|April 17, 2001
Is paraoxonase-3 another hdl-associated protein protective against atherosclerosis?B N La Du
Annual Review of Medicine|January 1, 1972
Pharmacogenetics: defective enzymes in relation to reactions to drugsB N La Du
World Review of Nutrition and Dietetics|January 1, 1990
The role of genetics in idiosyncratic reactions or adverse reactions to foodsB N La Du
Molecular Biology & Medicine|February 11, 1991
Alcaptonuria and ochronotic arthritisB N La Du
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Clinical Pharmacology and Therapeutics|November 1, 1977
Effects of GRAS substances on pharmacologic effects of drugsB N La Du
Acta Anaesthesiologica Scandinavica|February 1, 1995
Butyrylcholinesterase variants and the new methods of molecular biologyB N La Du
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1983
Commentary: drug metabolism and pharmacogeneticsB N La Du
Trends in Pharmacological Sciences|August 1, 1989
Identification of human serum cholinesterase variants using the polymerase chain reaction amplification techniqueB N La Du
American Journal of Human Genetics|June 13, 1998
Are we ready to try to cure alkaptonuria?B N La Du
Nature Medicine|November 1, 1996
Structural and functional diversity of paraoxonasesB N La Du
Arteriosclerosis, Thrombosis, and Vascular Biology|April 17, 2001
Is paraoxonase-3 another hdl-associated protein protective against atherosclerosis?B N La Du
Annual Review of Medicine|January 1, 1972
Pharmacogenetics: defective enzymes in relation to reactions to drugsB N La Du
World Review of Nutrition and Dietetics|January 1, 1990
The role of genetics in idiosyncratic reactions or adverse reactions to foodsB N La Du
Molecular Biology & Medicine|February 11, 1991
Alcaptonuria and ochronotic arthritisB N La Du
Pageof 9